Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × toripalimab × 30 days × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Mouth Neoplasms 1 Melanoma 1 Local Advanced Non-small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Tumors 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 29 Paclitaxel 12 Carboplatin 10 Cisplatin 7 Pemetrexed 5 Capecitabine 5 Saline Solution 4 Oxaliplatin 4 Gemcitabine 4 Fluorouracil 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 patritumab deruxtecan 3 Leucovorin 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 liposomal doxorubicin 2 lenvatinib 2 Irinotecan 2 Histamine H2 Antagonists 2 Histamine Antagonists 2 Glucose 2 Dexamethasone 2 Cetuximab 2 Acetaminophen 2 zanidatamab 1 trastuzumab deruxtecan 1 tislelizumab 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡